Correlation between miR-103 and miR-133a Expression and the Circulating ANGPTL8 in Type 2 Diabetic Patients and Healthy Control Subjects

被引:6
作者
Ghasemi, Hassan [1 ]
Karimi, Jamshid [2 ]
Khodadadi, Iraj [2 ]
Tavilani, Heidar [2 ]
机构
[1] Abadan Fac Med Sci, Dept Clin Biochem, Abadan, Iran
[2] Hamadan Univ Med Sci, Sch Med, Dept Biochem, Abadan, Iran
关键词
ANGPTL8; type 2 diabetes mellitus; miR-103; miR-133a; MICRORNAS; MIRNAS; BETATROPHIN; BIOMARKERS; METABOLISM; LIPASIN; CELLS;
D O I
10.7754/Clin.Lab.2019.190436
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Angiopoietin-like protein 8 (ANGPTL8) is a circulatory hormone that plays an important role in the proliferation of the pancreatic beta cells and lipid metabolism. MicroRNAs (miRs) are small non-coding RNAs that play an important role in the pathogenesis of diabetes mellitus. Therefore, we investigated the correlation of miR-103 and miR-133a expression with the ANGPTL8 and other type 2 diabetes mellitus (T2DM)-related factors. Methods: Seventy subjects (controls: n = 35 and type 2 diabetic patients: n = 35) participated in this study. The ANGPTL8 concentration and miR-103/133a expression were measured using ELISA and real-time PCR, respectively. Results: The circulatory ANGPTL8 concentration and miR-103/133a expression was significantly higher in T2D patients than in healthy controls (p < 0.05). There was a positive and significant correlation between miR-103/133a with triglycerides (TG), total cholesterol, fasting blood sugar (FBS), and glycated hemoglobin (p < 0.05) in the T2D group. The results also showed a negative and significant correlation between miR-103/133a expression with ANGPTL8 levels in the T2D group (p < 0.05). Conclusions: Our results suggest that miR-103/133a expression is correlated with the ANGPTL8 and T2D-related factors.
引用
收藏
页码:2149 / 2155
页数:7
相关论文
共 30 条
  • [1] ANGPTL8 (betatrophin) role in diabetes and metabolic diseases
    Abu-Farha, Mohamed
    Abubaker, Jehad
    Tuomilehto, Jaakko
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (08)
  • [2] Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc10-S011, 10.2337/dc13-S011, 10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc12-s011, 10.2337/dc10-S062, 10.2337/dc12-s064]
  • [3] Prevalence of Diabetes Mellitus and Its Risk Factors among Individuals Aged 15 Years and Above in Mizan-Aman Town, Southwest Ethiopia, 2016: A Cross Sectional Study
    Aynalem, Shiferaw Birhanu
    Zeleke, Ayalew Jejaw
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [4] The impact of microRNAs on protein output
    Baek, Daehyun
    Villen, Judit
    Shin, Chanseok
    Camargo, Fernando D.
    Gygi, Steven P.
    Bartel, David P.
    [J]. NATURE, 2008, 455 (7209) : 64 - U38
  • [5] Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes
    Baskerville, S
    Bartel, DP
    [J]. RNA, 2005, 11 (03) : 241 - 247
  • [6] Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats
    Delic, Denis
    Eisele, Claudia
    Schmid, Ramona
    Luippold, Gerd
    Mayoux, Eric
    Grempler, Rolf
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [7] Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity
    Fu, Zhiyao
    Berhane, Feven
    Fite, Alemu
    Seyoum, Berhane
    Abou-Samra, Abdul B.
    Zhang, Ren
    [J]. SCIENTIFIC REPORTS, 2014, 4
  • [8] Ghasemi Hassan, 2015, Chonnam Med J, V51, P115, DOI 10.4068/cmj.2015.51.3.115
  • [9] The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4
    Gray, S
    Feinberg, MW
    Hull, S
    Kuo, CT
    Watanabe, M
    Sen, S
    DePina, A
    Haspel, R
    Jain, MK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) : 34322 - 34328
  • [10] Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes
    Herrera, B. M.
    Lockstone, H. E.
    Taylor, J. M.
    Ria, M.
    Barrett, A.
    Collins, S.
    Kaisaki, P.
    Argoud, K.
    Fernandez, C.
    Travers, M. E.
    Grew, J. P.
    Randall, J. C.
    Gloyn, A. L.
    Gauguier, D.
    McCarthy, M. I.
    Lindgren, C. M.
    [J]. DIABETOLOGIA, 2010, 53 (06) : 1099 - 1109